| Year |
Citation |
Score |
| 2024 |
Williams MD, Morgan JS, Bullock MT, Poovey CE, Wisniewski ME, Francisco JT, Barajas-Nunez JA, Hijazi AM, Theobald D, Sriramula S, Mansfield KD, Holland NA, Tulis DA. pH-sensing GPR68 inhibits vascular smooth muscle cell proliferation through Rap1A. American Journal of Physiology. Heart and Circulatory Physiology. PMID 39269448 DOI: 10.1152/ajpheart.00413.2024 |
0.409 |
|
| 2023 |
Williams MD, Bullock MT, Johnson SC, Holland NA, Vuncannon DM, Oswald JZ, Adderley SP, Tulis DA. Protease-Activated Receptor 2 Controls Vascular Smooth Muscle Cell Proliferation in Cyclic AMP-Dependent Protein Kinase/Mitogen-Activated Protein Kinase Kinase 1/2-Dependent Manner. Journal of Vascular Research. 60: 213-226. PMID 37778342 DOI: 10.1159/000532032 |
0.427 |
|
| 2023 |
Francisco JT, Holt AW, Bullock MT, Williams MD, Poovey CE, Holland NA, Brault JJ, Tulis DA. FoxO3 normalizes Smad3-induced arterial smooth muscle cell growth. Frontiers in Physiology. 14: 1136998. PMID 37693008 DOI: 10.3389/fphys.2023.1136998 |
0.381 |
|
| 2022 |
Williams MD, Bullock MT, Holland NA, Johnson SC, Vuncannon DM, Oswald JZ, Adderley SP, Tulis DA. Protease-Activated Receptor-2 Differentially Regulates Vascular Smooth Muscle Cell Proliferation in Cyclic AMP-Dependent Protein Kinase/Phosphoinositide 3-Kinase-Dependent Manner. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35551775 DOI: 10.1096/fasebj.2022.36.S1.R3765 |
0.426 |
|
| 2020 |
Davis PR, Miller SG, Verhoeven NA, Morgan JS, Tulis DA, Witczak CA, Brault JJ. Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle. Metabolism: Clinical and Experimental. 154257. PMID 32370945 DOI: 10.1016/J.Metabol.2020.154257 |
0.362 |
|
| 2018 |
Holland NA, Francisco JT, Johnson SC, Morgan JS, Dennis TJ, Gadireddy NR, Tulis DA. Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth. Journal of Cardiovascular Development and Disease. 5. PMID 29367584 DOI: 10.3390/Jcdd5010006 |
0.444 |
|
| 2017 |
Tulis DA. Novel protein kinase targets in vascular smooth muscle therapeutics. Current Opinion in Pharmacology. 33: 12-16. PMID 28388507 DOI: 10.1016/J.Coph.2017.03.003 |
0.494 |
|
| 2016 |
Holt AW, Howard WE, Ables ET, George SM, Kukoly CA, Rabidou JE, Francisco JT, Chukwu AN, Tulis DA. Making the cut: Innovative methods for optimizing perfusion-based migration assays. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 27984679 DOI: 10.1002/Cyto.A.23033 |
0.357 |
|
| 2016 |
Holt AW, Martin DN, Shaver PR, Adderley SP, Stone JD, Joshi CN, Francisco JT, Lust RM, Weidner DA, Shewchuk BM, Tulis DA. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation. Cellular Signalling. PMID 27302407 DOI: 10.1016/J.Cellsig.2016.06.012 |
0.676 |
|
| 2015 |
Stone JD, Holt AW, Vuncannon JR, Brault JJ, Tulis DA. AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism. American Journal of Physiology. Heart and Circulatory Physiology. 309: H1251-9. PMID 26276823 DOI: 10.1152/Ajpheart.00846.2014 |
0.635 |
|
| 2015 |
Adderley SP, Martin DN, Tulis DA. Exchange protein activated by cAMP (EPAC) controls migration of vascular smooth muscle cells in concentration- and timedependent manner Archives of Physiology. 2: 2. DOI: 10.7243/2055-0898-2-2 |
0.37 |
|
| 2013 |
Johnson TL, Tulis DA, Keeler BE, Virag JA, Lust RM, Clemens S. The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis. Plos One. 8: e74116. PMID 24023697 DOI: 10.1371/Journal.Pone.0074116 |
0.486 |
|
| 2013 |
Holt AW, Tulis DA. Experimental Rat and Mouse Carotid Artery Surgery: Injury & Remodeling Studies. Isrn Minimally Invasive Surgery. 2013. PMID 23762781 DOI: 10.1155/2013/167407 |
0.404 |
|
| 2013 |
Stone JD, Narine A, Shaver PR, Fox JC, Vuncannon JR, Tulis DA. AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury. American Journal of Physiology. Heart and Circulatory Physiology. 304: H369-81. PMID 23203966 DOI: 10.1152/Ajpheart.00446.2012 |
0.693 |
|
| 2012 |
Stone JD, Narine A, Tulis DA. Inhibition of vascular smooth muscle growth via signaling crosstalk between AMP-activated protein kinase and cAMP-dependent protein kinase. Frontiers in Physiology. 3: 409. PMID 23112775 DOI: 10.3389/Fphys.2012.00409 |
0.671 |
|
| 2012 |
Joshi CN, Martin DN, Shaver P, Madamanchi C, Muller-Borer BJ, Tulis DA. Control of vascular smooth muscle cell growth by connexin 43. Frontiers in Physiology. 3: 220. PMID 22737133 DOI: 10.3389/Fphys.2012.00220 |
0.521 |
|
| 2012 |
Peyton KJ, Shebib AR, Azam MA, Liu XM, Tulis DA, Durante W. Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration. Frontiers in Pharmacology. 3: 48. PMID 22470341 DOI: 10.3389/Fphar.2012.00048 |
0.513 |
|
| 2012 |
Adderley SP, Joshi CN, Martin DN, Tulis DA. Phosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells. Frontiers in Pharmacology. 3: 10. PMID 22347188 DOI: 10.3389/Fphar.2012.00010 |
0.513 |
|
| 2011 |
Joshi CN, Martin DN, Fox JC, Mendelev NN, Brown TA, Tulis DA. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways. The Journal of Pharmacology and Experimental Therapeutics. 339: 394-402. PMID 21825001 DOI: 10.1124/Jpet.111.183400 |
0.543 |
|
| 2009 |
Keswani AN, Peyton KJ, Durante W, Schafer AI, Tulis DA. The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects. Journal of Cardiovascular Pharmacology and Therapeutics. 14: 116-24. PMID 19342499 DOI: 10.1177/1074248409333266 |
0.527 |
|
| 2009 |
Mendelev NN, Williams VS, Tulis DA. Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells. Journal of Cardiovascular Pharmacology. 53: 121-31. PMID 19188837 DOI: 10.1097/Fjc.0B013E31819715C4 |
0.559 |
|
| 2009 |
Peyton KJ, Ensenat D, Azam MA, Keswani AN, Kannan S, Liu XM, Wang H, Tulis DA, Durante W. Arginase promotes neointima formation in rat injured carotid arteries. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 488-94. PMID 19164802 DOI: 10.1161/Atvbaha.108.183392 |
0.498 |
|
| 2009 |
Liu XM, Peyton KJ, Mendelev NN, Wang H, Tulis DA, Durante W. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells. Molecular Pharmacology. 75: 208-17. PMID 18923065 DOI: 10.1124/Mol.108.048314 |
0.447 |
|
| 2008 |
Tulis DA. Novel therapies for cyclic GMP control of vascular smooth muscle growth. American Journal of Therapeutics. 15: 551-64. PMID 19127140 DOI: 10.1097/Mjt.0B013E318140052F |
0.48 |
|
| 2007 |
Tulis DA. Histological and morphometric analyses for rat carotid balloon injury model. Methods in Molecular Medicine. 139: 31-66. PMID 18287663 DOI: 10.1007/978-1-59745-571-8_2 |
0.435 |
|
| 2007 |
Tulis DA. Rat carotid artery balloon injury model. Methods in Molecular Medicine. 139: 1-30. PMID 18287662 DOI: 10.1007/978-1-59745-571-8_1 |
0.427 |
|
| 2007 |
Jackson EB, Mukhopadhyay S, Tulis DA. Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system - from bench top to bedside. Current Vascular Pharmacology. 5: 1-14. PMID 17266609 DOI: 10.2174/157016107779317224 |
0.463 |
|
| 2006 |
Tulis DA. Methods for identifying cardiovascular agents: a review. Recent Patents On Cardiovascular Drug Discovery. 1: 47-56. PMID 18221073 DOI: 10.2174/157489006775244236 |
0.413 |
|
| 2006 |
Yang X, Thomas DP, Zhang X, Culver BW, Alexander BM, Murdoch WJ, Rao MN, Tulis DA, Ren J, Sreejayan N. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 85-90. PMID 16239599 DOI: 10.1161/01.Atv.0000191635.00744.B6 |
0.537 |
|
| 2005 |
Tulis DA, Keswani AN, Peyton KJ, Wang H, Schafer AI, Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cellular and Molecular Biology (Noisy-Le-Grand, France). 51: 441-6. PMID 16309565 DOI: 10.1170/T648 |
0.328 |
|
| 2005 |
Masters KS, Lipke EA, Rice EE, Liel MS, Myler HA, Zygourakis C, Tulis DA, West JL. Nitric oxide-generating hydrogels inhibit neointima formation. Journal of Biomaterials Science. Polymer Edition. 16: 659-72. PMID 16001723 DOI: 10.1163/1568562053783722 |
0.406 |
|
| 2005 |
Tulis D, Durante W, Schafer A. Nitric oxide-independent regulation of the vascular injury response Bmc Pharmacology. 5: S25. DOI: 10.1186/1471-2210-5-S1-S25 |
0.525 |
|
| 2004 |
Tulis DA. Salutary properties of YC-1 in the cardiovascular and hematological systems. Current Medicinal Chemistry. Cardiovascular and Hematological Agents. 2: 343-59. PMID 15320784 DOI: 10.2174/1568016043356200 |
0.461 |
|
| 2004 |
Durante W, Tulis DA, KeswaniI AN, Wang H, Peyton KJ. ARGINASE PROMOTES VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMA FORMATION Cardiovascular Pathology. 13: 46. DOI: 10.1016/J.Carpath.2004.03.131 |
0.443 |
|
| 2003 |
Tulis DA, Mnjoyan ZH, Schiesser RL, Shelat HS, Evans AJ, Zoldhelyi P, Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation. 107: 98-105. PMID 12515750 DOI: 10.1161/01.Cir.0000047675.86603.Eb |
0.403 |
|
| 2002 |
Yuan Y, Liao L, Tulis DA, Xu J. Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen. Circulation. 105: 2653-9. PMID 12045172 DOI: 10.1161/01.Cir.0000018947.95555.65 |
0.465 |
|
| 2002 |
Tulis DA, Bohl Masters KS, Lipke EA, Schiesser RL, Evans AJ, Peyton KJ, Durante W, West JL, Schafer AI. YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. Biochemical and Biophysical Research Communications. 291: 1014-21. PMID 11866467 DOI: 10.1006/Bbrc.2002.6552 |
0.482 |
|
| 2001 |
Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 104: 2710-5. PMID 11723024 DOI: 10.1161/Hc4701.099585 |
0.391 |
|
| 2001 |
Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis. 155: 113-22. PMID 11223432 DOI: 10.1016/S0021-9150(00)00552-9 |
0.377 |
|
| 2000 |
Tulis DA, Durante W, Peyton KJ, Chapman GB, Evans AJ, Schafer AI. YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochemical and Biophysical Research Communications. 279: 646-52. PMID 11118339 DOI: 10.1006/Bbrc.2000.3942 |
0.424 |
|
| Show low-probability matches. |